-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Heron Therapeutics, Inc. /De/ quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2011 to 2024.
- Heron Therapeutics, Inc. /De/ Share-based Payment Arrangement, Expense for the quarter ending March 31, 2025 was $2.51M, a 25.6% decline year-over-year.
- Heron Therapeutics, Inc. /De/ Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2025 was $12.1M, a 57.2% decline year-over-year.
- Heron Therapeutics, Inc. /De/ annual Share-based Payment Arrangement, Expense for 2024 was $13M, a 60.5% decline from 2023.
- Heron Therapeutics, Inc. /De/ annual Share-based Payment Arrangement, Expense for 2023 was $32.9M, a 23.6% decline from 2022.
- Heron Therapeutics, Inc. /De/ annual Share-based Payment Arrangement, Expense for 2022 was $43M, a 8.26% decline from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)